Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study Evaluating DT402 in Adults With Autism Spectrum Disorder

NCT07303907 is registered in ClinicalTrials.gov with Definium Therapeutics US, Inc. as lead sponsor.

NCT NCT07303907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07303907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study Evaluating DT402 in Adults With Autism Spectrum Disorder
Lead sponsor
Definium Therapeutics US, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
December 3, 2025
Completion date
August 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asd, autism spectrum disorder